Dec. 11, 2023

120. Dr. Feldman on MENTAL ACCOUNTING - Avapritinib for systemic mastocytosis - IL-17-blockers: smaaaaall risk of IBD - Dermasphere clip show: Episodes 111-119!

120. Dr. Feldman on MENTAL ACCOUNTING - Avapritinib for systemic mastocytosis - IL-17-blockers: smaaaaall risk of IBD - Dermasphere clip show: Episodes 111-119!
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconOvercast podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconOvercast podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon

Dr. Feldman on MENTAL ACCOUNTING -

Avapritinib for systemic mastocytosis -

IL-17-blockers: smaaaaall risk of IBD -

Dermasphere clip show: Episodes 111-119! -

Want to donate to the cause? Do so here! http://www.uofuhealth.org/dermasphere

Check out our video content on YouTube: https://www.youtube.com/@dermaspherepodcast

and VuMedi!: https://www.vumedi.com/channel/dermasphere/

The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare -

⁠⁠Connect with us!

- Web: ⁠https://dermaspherepodcast.com/⁠

- Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: https://www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠

Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:

- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)

- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)